How menthol alters tobacco-smoking behavior: A biological perspective

Yale Journal of Biology and Medicine

Volumn 88, Issue 3, 2015, Pages 279-287

  Wickham, R J ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

Acetylcholine; Addiction; Menthol; Nicotine; Tobacco cigarettes

Indexed keywords

MENTHOL; NICOTINE; NICOTINIC RECEPTOR;

ASSOCIATION; AVERSION; DESENSITIZATION; DOPAMINERGIC NERVE CELL; EXPERIENCE; FLAVOR; HUMAN; METABOLISM; NONHUMAN; REINFORCEMENT; REVIEW; SMOKING; SMOKING CESSATION; SYNAPSE; TOBACCO DEPENDENCE; ADDICTION; ANIMAL; BIOLOGICAL MODEL; BRAIN; CHEMICALLY INDUCED; DRUG EFFECTS; DRUG POTENTIATION; HEALTH BEHAVIOR; PATHOPHYSIOLOGY;

ANIMALS; BEHAVIOR, ADDICTIVE; BRAIN; DRUG SYNERGISM; HEALTH BEHAVIOR; HUMANS; MENTHOL; MODELS, BIOLOGICAL; NICOTINE; REINFORCEMENT (PSYCHOLOGY); SMOKING;

EID: 84940749189     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Alberg AJ, Shopland DR, Cummings KM. The 2014 Surgeon General's report: commemorating the 50th Anniversary of the 1964 Report of the Advisory Committee to the US Surgeon General and updating the evidence on the health consequences of cigarette smoking. Am J epidemiol. 2014;179(4):403-12.
2. Kreslake JM, Wayne GF, Alpert HR, Koh HK, Connolly GN. Tobacco industry control of menthol in cigarettes and tar- geting of adolescents and young adults. Am J Public Health. 2008;98(9):1685-92.
3. Kreslake JM, Wayne GF, Connolly GN. The menthol smoker: tobacco industry research on consumer sensory perception of menthol cigarettes and its role in smoking behavior. Nicotine Tob Res. 2008;10(4):705-15.
4. Giovino GA, Sidney S, Gfroerer JC, O'Malley PM, Allen JA, Richter PA, et al. epidemiology of menthol cigarette use. Nicotine Tob Res. 2004;6 Suppl 1:S67-81.
5. Hersey JC, Ng SW, Nonnemaker JM, Mowery P, Thomas KY, Vilsaint MC, et al. Are menthol cigarettes a starter product for youth? Nicotine Tob Res. 2006;8(3):403-13.
6. Pletcher MJ, Hulley BJ, Houston T, Kiefe CI, Benowitz N, Sidney S. Menthol cigarettes, smoking cessation, atherosclerosis, and pulmonary function: the Coronary Artery Risk Development in Young Adults (CARDiA) Study. Arch intern Med. 2006;166(17):1915-22.
7. Levy DT, Blackman K, Tauras J, Chaloupka FJ, Villanti AC, Niaura RS, et al. Quit attempts and quit rates among menthol and nonmenthol smokers in the United States. Am J Public Health. 2011;101(7):1241-7.
8. Smith SS, Fiore MC, Baker TB. Smoking cessation in smokers who smoke menthol and non-menthol cigarettes. Addiction. 2014;109(12):2107-17.
9. Ahijevych K, Parsley LA. Smoke constituent exposure and stage of change in black and white women cigarette smokers. Addict Behav. 1999;24(1):115-20.
10. Hyland A, Garten S, Giovino GA, Cummings KM. Mentholated cigarettes and smoking cessation: findings from COMMiT. Community intervention Trial for Smoking Cessation. Tob Control. 2002;11(2):135-9.
11. McKemy DD, Neuhausser WM, Julius D. identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature. 2002;416(6876):52-8.
12. Willis DN, Liu B, Ha MA, Jordt SE, Morris JB. Menthol attenuates respiratory irritation responses to multiple cigarette smoke irritants. Faseb J. 2011;25(12):4434-44.
13. Caskey NH, Jarvik ME, McCarthy WJ, Rosenblatt MR, Gross TM, Carpenter CL. Rapid smoking of menthol and nonmenthol cigarettes by black and white smokers. Pharmacol Biochem Behav. 1993;46(2):259-63.
14. Ahijevych K, Gillespie J, Demirci M, Jagadeesh J. Menthol and nonmenthol cigarettes and smoke exposure in black and white women. Pharmacol Biochem Behav. 1996;53(2):355-60.
15. Kong G, Morean ME, Cavallo DA, Camenga DR, Krishnan- Sarin S. Reasons for electronic Cigarette experimentation and Discontinuation Among Adolescents and Young Adults. Nicotine Tob Res. 2015;17(7):847-54.
16. Klein SM, Giovino GA, Barker DC, Tworek C, Cummings KM, O'Connor RJ. Use of flavored cigarettes among older adolescent and adult smokers: United States, 2004-2005. Nicotine Tob Res. 2008;10(7):1209-14.
17. Carpenter CM, Wayne GF, Pauly JL, Koh HK, Connolly GN. New cigarette brands with flavors that appeal to youth: tobacco marketing strategies. Health Aff (Millwood). 2005;24(6):1601-10.
18. Villanti AC, Richardson A, Vallone DM, Rath JM. Flavored tobacco product use among U.S. young adults. Am J Prev Med. 2013;44(4):388-91.
19. Krishnan-Sarin S, Morean ME, Camenga DR, Cavallo DA, Kong G. e-cigarette Use Among High School and Middle School Adolescents in Connecticut. Nicotine Tob Res. 2015;17(7):810-8.
20. Warner LA, Kessler RC, Hughes M, Anthony JC, Nelson CB. Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52(3):219-29.
21. Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the national comorbidity survey. exp Clin Psychopharmacol. 1994;2:244-68.
22. Caggiula AR, Donny EC, Palmatier MI, Liu X, Chaudhri N, Sved AF. The role of nicotine in smoking: a dual-reinforcement model. Nebr Symp Motiv. 2009;55:91-109.
23. Corrigall WA, Coen KM. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology (Berl). 1989;99(4):473-8.
24. Bardo MT, Green TA, Crooks PA, Dwoskin LP. Nornicotine is self-administered intravenously by rats. Psychopharmacology (Berl). 1999;146(3):290-6.
25. Smith TT, Levin ME, Schassburger RL, Buffalari DM, Sved AF, Donny EC. Gradual and immediate nicotine reduction result in similar low-dose nicotine self-administration. Nicotine Tob Res. 2013;15(11):1918-25.
26. Rose JE, Behm FM, Westman EC, Johnson M. Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacol Biochem Behav. 2000;67(1):71-81.
27. Chaudhri N, Caggiula AR, Donny EC, Booth S, Gharib M, Craven L, et al. Operant responding for conditioned and unconditioned reinforcers in rats is differentially enhanced by the primary reinforcing and reinforcement-enhancing effects of nicotine. Psychopharmacology (Berl). 2006;189(1):27-36.
28. Donny EC, Chaudhri N, Caggiula AR, Evans-Martin FF, Booth S, Gharib MA, et al. Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement. Psychopharmacology (Berl.) 2003;169(1):68-76.
29. Caggiula AR, Donny EC, Chaudhri N, Perkins KA, Evans-Martin FF, Sved AF. importance of nonpharmacological factors in nicotine self-administration. Physiol Behav. 2002;77(4-5):683-7.
30. Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA, et al. environmental stimuli promote the acquisition of nicotine self-administration in rats. Psychopharmacology (Berl). 2002;163(2):230-7.
31. Rose JE, Behm FM. extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments. Nicotine Tob Res. 2004;6(3):523-32.
32. Wang T, Wang B, Chen H. Menthol facilitates the intravenous self-administration of nicotine in rats. Front Behav Neurosci. 2014;8:437.
33. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev. 2009;89(1):73-120.
34. Galzi JL, Changeux JP. Neuronal nicotinic receptors: molecular organization and regulations. Neuropharmacology. 1995;34(6):563-82.
35. Cooper E, Couturier S, Ballivet M. Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature. 1991;350(6315):235-8.
36. Zoli M, Pistillo F, Gotti C. Diversity of native nicotinic receptor subtypes in mammalian brain. Neuropharmacology. 2015;96(Pt B):302-11.
37. Grace AA, Bunney BS. The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci. 1984;4(11):2877- 90.
38. Grace AA, Bunney BS. The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci. 1984;4(11):2866-76.
39. Grace AA, Bunney BS. intracellular and extracellular electrophysiology of nigral dopaminergic neurons--3. evidence for electrotonic coupling. Neuroscience. 1983;10(2):333-48.
40. Hyland BI, Reynolds JN, Hay J, Perk CG, Miller R. Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience. 2002;114(2):475-92.
41. Cheer JF, Wassum KM, Sombers LA, Heien M, Ariansen JL, Aragona BJ, et al. Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci. 2007;27(4):791-5.
42. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA. 1988;85(14):5274-8.
43. Aragona BJ, Cleaveland NA, Stuber GD, Day JJ, Carelli RM, Wightman RM. Preferential enhancement of dopamine transmission within the nucleus accumbens shell by cocaine is attributable to a direct increase in phasic dopamine release events. J Neurosci. 2008;28(35):8821-31.
44. Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, Pich EM, et al. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature. 1998;391(6663):173-7.
45. Rice ME, Cragg SJ. Nicotine amplifies reward-related dopamine signals in striatum. Nat Neurosci. 2004;7(6):583-4.
46. Zhang H, Sulzer D. Frequency-dependent modulation of dopamine release by nicotine. Nat Neurosci. 2004;7(6):581-2.
47. Zhang T, Zhang L, Liang Y, Siapas AG, Zhou FM, Dani JA. Dopamine Signaling Differences in the Nucleus Accumbens and Dorsal Striatum exploited by Nicotine. J Neurosci. 2009;29(13):4035-43.
48. Zhang H, Sulzer D. Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors. Basal Ganglia. 2012;2(1):5-13.
49. Ikemoto S. Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev. 2007;56(1):27-78.
50. Keath JR, Iacoviello MP, Barrett LE, Mansvelder HD, McGehee DS. Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons. J Neurophysiol. 2007;98(6):3388-96.
51. Mameli-engvall M, Evrard A, Pons S, Maskos U, Svensson TH, Changeux JP, et al. Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron. 2006;50(6):911-21.
52. Hans M, Wilhelm M, Swandulla D. Menthol suppresses nicotinic acetylcholine receptor functioning in sensory neurons via allosteric modulation. Chem Senses. 2012;37(5):463-9.
53. Ashoor A, Nordman JC, Veltri D, Yang KH, Al Kury L, Shuba Y, et al. Menthol binding and inhibition of alpha7-nicotinic acetylcholine receptors. PLoS One. 2013;8(7):e67674.
54. Govind AP, Vezina P, Green WN. Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction. Biochem Pharmacol. 2009;78(7):756-65.
55. Govind AP, Walsh H, Green WN. Nicotine-induced upregulation of native neuronal nicotinic receptors is caused by multiple mechanisms. J Neurosci. 2012;32(6):2227-38.
56. Brody AL, Mukhin AG, La Charite J, Ta K, Farahi J, Sugar CA, et al. Up-regulation of nicotinic acetylcholine receptors in menthol cigarette smokers. int J Neuropsychopharmacol. 2013;16(5):957-66.
57. Lerman C, Tyndale R, Patterson F, Wileyto EP, Shields PG, Pinto A, et al. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin Pharmacol Ther. 2006;79(6):600-8.
58. Johnstone E, Benowitz N, Cargill A, Jacob R, Hinks L, Day I, et al. Determinants of the rate of nicotine metabolism and effects on smoking behavior. Clin Pharmacol Ther. 2006;80(4):319-30.
59. Kandel DB, Hu MC, Schaffran C, Udry JR, Benowitz NL. Urine nicotine metabolites and smoking behavior in a multiracial/ multiethnic national sample of young adults. Am J epidemiol. 2007;165(8):901-10.
60. Benowitz NL, Hukkanen J, Jacob P 3rd. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb exp Pharmacol. 2009;(192):29-60.
61. Messina ES, Tyndale RF, Sellers EM. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol exp Ther. 1997;282(3):1608-14.
62. Rubinstein ML, Shiffman S, Rait MA, Benowitz NL. Race, gender, and nicotine metabolism in adolescent smokers. Nicotine Tob Res. 2013;15(7):1311-5.
63. Benowitz NL, Perez-Stable EJ, Fong I, Modin G, Herrera B, Jacob P 3rd. ethnic differences in N-glucuronidation of nicotine and cotinine. J Pharmacol exp Ther. 1999;291(3):1196- 203.
64. Benowitz NL, Perez-Stable EJ, Herrera B, Jacob P 3rd. Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. J Natl Cancer inst. 2002;94(2):108-15.
65. Perez-Stable EJ, Benowitz NL. Do biological differences help explain tobacco-related disparities? Am J Health Promot. 2011;25(5 Suppl):S8-10.
66. Perez-Stable EJ, Herrera B, Jacob P 3rd, Benowitz NL. Nicotine metabolism and intake in black and white smokers. JAMA. 1998;280(2):152-6.
67. Benowitz NL, Herrera B, Jacob P 3rd. Mentholated cigarette smoking inhibits nicotine metabolism. J Pharmacol exp Ther. 2004;310(3):1208-15.
68. Rubinstein ML, Shiffman S, Moscicki AB, Rait MA, Sen S, Benowitz NL. Nicotine metabolism and addiction among adolescent smokers. Addiction. 2013;108(2):406-12.
69. Klink R, de Kerchove d'exaerde A, Zoli M, Changeux JP. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci. 2001;21(5):1452-63.
70. Grady SR, Drenan RM, Breining SR, Yohannes D, Wageman CR, Fedorov NB, et al. Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptors. Neuropharmacology. 2010;58(7):1054-66.
71. Grady SR, Salminen O, Laverty DC, Whiteaker P, Mcintosh JM, Collins AC, et al. The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. Biochem Pharmacol. 2007;74(8):1235-46.
72. Grady SR, Salminen O, Mcintosh JM, Marks MJ, Collins AC. Mouse striatal dopamine nerve terminals express alpha4alpha5beta2 and two stoichiometric forms of alpha4beta2*-nicotinic acetylcholine receptors. J Mol Neurosci. 2010;40(1-2):91-5.